Depletion of O 6-methylguanine-DNA methyltransferase by O 6-benzylguanine enhances 5-FU cytotoxicity in colon and oral cancer cell lines

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypermethylation of O[6]-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases

  2004cited by this paper
• Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors

  2004cited by this paper
• High Expression of Thymidylate Synthase Leads to Resistance to 5‐Fluorouracil in Biliary Tract Carcinoma in vitro

  2001cited by this paper
• Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

  2000cited by this paper
• Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells.

  2000cited by this paper
• Influence of O6-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice

  1999cited by this paper
• Mismatch repair proficiency and in vitro response to 5-fluorouracil.

  1999cited by this paper
• Reduced lung tumorigenesis in human methylguanine DNA--methyltransferase transgenic mice achieved by expression of transgene within the target cell.

  1999cited by this paper
• Resistance to 5-fluorouracil.

  1998cited by this paper
• Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

  1998cited by this paper
• O6-benzylguanine and its role in chemotherapy.

  1997cited by this paper
• Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene

  1997cited by this paper
• Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

  1995cited by this paper
• A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

  1994cited by this paper
• Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.

  1993cited by this paper
• Depletion of O6-methylguanine-DNA methyltransferase and potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea antitumor activity by O6-benzylguanine in vitro.

  1993cited by this paper
• Prolonged depletion of O6-methylguanine DNA methyltransferase activity following exposure to O6-benzylguanine with or without streptozotocin enhances 1,3-bis(2-chloroethyl)-1-nitrosourea sensitivity in vitro.

  1993cited by this paper
• Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.

  1993cited by this paper
• The role of O6-alkylguanine in cell killing and mutagenesis in Chinese hamster ovary cells.

  1991cited by this paper
• Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines.

  1991cited by this paper
• Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine.

  1991cited by this paper
• Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.

  1990cited by this paper
• Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

  1990cited by this paper
• Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.

  1990cited by this paper
• Inactivation of O6-alkylguanine-DNA alkyltransferase in HeLa cells by cisplatin.

  1989cited by this paper
• O6-methylguanine methyltransferase activity and sensitivity of Japanese tumor cell strains to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)- 3-nitrosourea hydrochloride.

  1987cited by this paper
• Formation of DNA interstrand cross-links by the novel chloroethylating agent 2-chloroethyl(methylsulfonyl)methanesulfonate: suppression by O6-alkylguanine-DNA alkyltransferase purified from human leukemic lymphoblasts.

  1987cited by this paper
• Suppression of cross-link formation in chloroethylnitrosourea-treated DNA by an activity in extracts of human leukemic lymphoblasts.

  1984cited by this paper
• Removal of O6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid lines

  1981cited by this paper
• Defective repair of alkylated DNA by human tumour and SV40-transformed human cell strains

  1980cited by this paper
• Human tumor cell strains defective in the repair of alkylation damage.

  1980cited by this paper

• Chemotherapy in Neuroendocrine Tumors

  2021cites this paper
• Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma

  2020cites this paper
• Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms

  2019cites this paper
• Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

  2019cites this paper
• RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance

  2019cites this paper
• Temozolomide in Advanced Neuroendocrine Neoplasms: Pharmacological and Clinical Aspects

  2015cites this paper
• Acetylation of Werner syndrome protein (WRN): relationships with DNA damage, DNA replication and DNA metabolic activities

  2014cites this paper
• Epigenetic biomarkers in colorectal cancer diagnostics

  2012cites this paper